Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 52

Yunhu delivers series A-plus

The medical research services provider collected funding from investors including Cash Capital, an investment arm of CAS which previously backed a series A.

Mar 15, 2019

Via Separations marks $4.8m series A vintage

MIT's The Engine has returned to back membrane-based separation technology spinout Via Separations, after previously investing an undisclosed sum in 2017.

Mar 14, 2019

FanFood munches on $2m

The series A round reportedly featured UCLA Ventures, with the cash going towards expanding the business and technology for FanFood’s events concession app.

Mar 14, 2019

PolyAI understands $12m series A

The Cambridge spinout plans to build out the business for its automated customer support platform after collecting $12m in series A funding.

Mar 11, 2019

NovaGo collects $10m

Zurich brain injury antibody spinout NovaGo has extended its strategic partnership with immunotherapy company Neurimmune by securing its support in a series A round.

Mar 6, 2019

Maze finds its way to $191m

GV and Alexandria have taken part in a $191m round to launch Maze Therapeutics with scientific co-founders from multiple universities such as Harvard and Stanford.

Mar 1, 2019

PetMedix paddles to $10.6m series A

Sanger Institute-founded PetMedix is working on antibodies for dogs and cats based on an immune system discovery model that will adapt and extend earlier human health research.

Mar 1, 2019

GV sees Lightmatter for series A extension

Alphabet's venturing unit has led a $22m series A extension for MIT spinout Lightmatter, which increased the round's total to $33m.

Feb 28, 2019

Anaveon validates Novartis for series A

Zurich immuno-oncology spinout Anaveon raised $35.1m from Novartis Venture Fund and Syncona in addition to seed-stage notes converted by the UZH Life Sciences Fund.

Feb 27, 2019

Motif Ingredients structures $90m series A

MIT spinout Ginkgo Bioworks has set up Motif Ingredients with $90m in series A funding provided by investors including Louis Dreyfus Company and Fonterra.

Feb 27, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here